REQUEST A DEMO
Total
USD $0.00
Search more companies

Lakshmidurga Drugs & Intermediates Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lakshmidurga Drugs & Intermediates Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lakshmidurga Drugs & Intermediates Private Limited is an unlisted company, incorporated on 15/05/2009. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24233TG2009PTC063687 and registration number is 063687. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Plot No.26, Venkata Sai Enclave, 101, Noble Residency, Nizampet, K.P.H.B,
Hyderabad; Telangana; Postal Code: 500072

Contact Details: Purchase the Lakshmidurga Drugs & Intermediates Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Lakshmidurga Drugs & Intermediates Private Limited report to view the information.
Outstanding Shares:
Purchase the Lakshmidurga Drugs & Intermediates Private Limited report to view the information.
Registered Capital:
Purchase the Lakshmidurga Drugs & Intermediates Private Limited report to view the information.
Incorporation Date:
May 15, 2009
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
34.33%
Purchase this report to view the information.
29.58%
Company Performance
Financial values in the chart are available after Lakshmidurga Drugs & Intermediates Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
72.79%
Total operating revenue
72.79%
Operating profit (EBIT)
40.56%
EBITDA
24.09%
Net Profit (Loss) for the Period
44.12%
Total assets
37.84%
Total equity
23.92%
Operating Profit Margin (ROS)
-0.71%
Net Profit Margin
-0.46%
Return on Equity (ROE)
2.06%
Debt to Equity Ratio
-35.76%
Quick Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?